ReviewBritish journal of pharmacology2019

β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Xiao-Jun Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.